ScholarIQanswers from OpenAlex & ORCID
Ragini R. Kudchadkar
ResearcherPublications, citations & collaboration network
Ragini R. Kudchadkar is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Ragini R. Kudchadkar have?
ScholarIQindexed works
Ragini R. Kudchadkar has 233 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Ragini R. Kudchadkar have?
ScholarIQcitation count
Ragini R. Kudchadkar has 16,968 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Ragini R. Kudchadkar?
ScholarIQh-index
Ragini R. Kudchadkar has an h-index of 54 in OpenAlex.
What is the i10-index of Ragini R. Kudchadkar?
ScholarIQi10-index
Ragini R. Kudchadkar has an i10-index of 105 in OpenAlex.
What is the ORCID of Ragini R. Kudchadkar?
ScholarIQorcid
The ORCID for Ragini R. Kudchadkar is on the source record.
What is the OpenAlex record for Ragini R. Kudchadkar?
ScholarIQopenalex
The OpenAlex for Ragini R. Kudchadkar is on the source record.
What are the most-cited papers on Ragini R. Kudchadkar?
ScholarIQmost cited works
Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial
Michael R. Migden, Alexander Guminski, Ralf Gutzmer, Luc Dirix, Karl D. Lewis, P. Combemale, R. M. Herd, Ragini R. Kudchadkar, Uwe Trefzer, Sven Gogov, Céline Pallaud, Tingting Yi, Manisha Mone, Martin Kaatz, Carmen Loquai, Alexander Stratigos, H. J. Schulze, Ruth Plummer, Anne Lynn S. Chang, Frank Cornélis, John T. Lear, Dalila Sellami, Reinhard Dummer
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial
Alexander Eggermont, Christian U. Blank, Mario Mandalà, Georgina V Long, Victoria Atkinson, Stéphane Dalle, Andrew Haydon, Andrey Meshcheryakov, Adnan Khattak, Matteo S. Carlino, Shahneen Sandhu, James Larkin, Susana Puig, Paolo A. Ascierto, Piotr Rutkowski, Dirk Schadendorf, Rutger H.T. Koornstra, Leonel F. Hernandez‐Aya, Anna Maria Di Giacomo, Alfons J.M. van den Eertwegh, Jean‐Jacques Grob, Ralf Gutzmer, Rahima Jamal, Paul Lorigan, Alexander C. J. van Akkooi, Clemens Krepler, Nageatte Ibrahim, Sandrine Marréaud, Michal Kiciński, Stefan Suciu, Caroline Robert, Alex Menzies, Thierry Lesimple, Michele Maio, Gerald P. Linette, Michael P. Brown, Peter Hersey, Inge Marie Svane, Laurent Mortier, Jacob Schachter, Catherine Barrow, Ragini R. Kudchadkar, Xinni Song, Caroline Dutriaux, Pietro Quaglino, Friedegund Meier, Paola Queirolo, Daniil Stroyakovskiy, Lars Bastholt, B. Guillot, Claus Garbe, Pablo L. Ortiz‐Romero, Florent Grange, Peter Mohr, Alain P. Algazi, Oliver Bechter, Micaela Hernberg, Jean‐Philippe Arnault, Philippe Saïag, Carmen Loquai, Frank Meiß, Jan‐Christoph Simon, Gil Bar‐Sela, Vanna Chiarion‐Sileni, Bernard M. Fitzharris, Mike McCrystal, Phillip Parente, Jean‐François Baurain, P. Combemale, Célèste Lebbé, Axel Hauschild, Naoya Yamazaki, Reinhard Dummer, Mohammed Milhem, Marcin Dzienis, John Walker, L. Geoffrois, M.‐T. Leccia, Lutz Kretschmer, Daniel Hendler, Michal Lotem, Andrzej Maćkiewicz, Lidija Kandolf Sekulović, Elaine Dunwoodie, Christoph Höeller, L. Machet, Jessica C. Hassel, Geke A.P. Hospers, Maria-Jose Passos, Max Levin, Martin Fehr, Philippa Corrie, Ashita Waterston, Sigrun Hallmeyer, Henrik Schmidt, V. Descamps, J.‐P. Lacour, Carola Berking, Felix Kiecker, Pier Francesco Ferrucci
Long‐term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42‐month analysis of the phase II randomized, double‐blind BOLT study
Reinhard Dummer, Alexander D. Guminksi, Ralf Gutzmer, John T. Lear, Karl D. Lewis, Anne Lynn S. Chang, P. Combemale, Luc Dirix, Martin Kaatz, Ragini R. Kudchadkar, Carmen Loquai, Ruth Plummer, H.‐J. Schulze, Alexander Stratigos, Uwe Trefzer, Nicholas Squittieri, Michael R. Migden
Long‐term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30‐month analysis of the randomized phase 2 BOLT study
John T. Lear, Michael R. Migden, Karl D. Lewis, Anne Lynn S. Chang, Alexander Guminski, Ralf Gutzmer, Luc Dirix, P. Combemale, Alexander Stratigos, Ruth Plummer, Henry Castro, Tingting Yi, Manisha Mone, J ZHOU, Uwe Trefzer, Martin Kaatz, Carmen Loquai, Ragini R. Kudchadkar, Dalila Sellami, Reinhard Dummer
Prevention of Dietary-Fat-Fueled Ketogenesis Attenuates BRAF V600E Tumor Growth
Siyuan Xia, Ruiting Lin, Lingtao Jin, Liang Zhao, Hee‐Bum Kang, Yaozhu Pan, Shuangping Liu, Guoqing Qian, Zhiyu Qian, Evmorfia Konstantakou, Baotong Zhang, Jin‐Tang Dong, Young Rock Chung, Omar Abdel‐Wahab, Taha Merghoub, Lu Zhou, Ragini R. Kudchadkar, David H. Lawson, H. Jean Khoury, Fadlo R. Khuri, Lawrence Boise, Sagar Lonial, Benjamin H. Lee, Brian P. Pollack, Jack L. Arbiser, Jun Fan, Qun‐Ying Lei, Jing Chen